BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 20376786)

  • 21. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
    Peidl A; Perbal B; Leask A
    PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulation and functions of the matricellular CCN proteins induced by shear stress.
    Wang YK; Weng HK; Mo FE
    J Cell Commun Signal; 2023 Jun; 17(2):361-370. PubMed ID: 37191841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells.
    Leu SJ; Lam SC; Lau LF
    J Biol Chem; 2002 Nov; 277(48):46248-55. PubMed ID: 12364323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CCN family of genes: a perspective on CCN biology and therapeutic potential.
    Yeger H; Perbal B
    J Cell Commun Signal; 2007 Dec; 1(3-4):159-64. PubMed ID: 18568428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYR61 (CCN1) is essential for placental development and vascular integrity.
    Mo FE; Muntean AG; Chen CC; Stolz DB; Watkins SC; Lau LF
    Mol Cell Biol; 2002 Dec; 22(24):8709-20. PubMed ID: 12446788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.
    Pasmant E; Ortonne N; Rittié L; Laurendeau I; Lévy P; Lazar V; Parfait B; Leroy K; Dessen P; Valeyrie-Allanore L; Perbal B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I
    J Neuropathol Exp Neurol; 2010 Jan; 69(1):60-9. PubMed ID: 20010302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of the CCN genes in the lungs of mice in response to cigarette smoke exposure and viral and bacterial infections.
    Gueugnon F; Thibault VC; Kearley J; Petit-Courty A; Vallet A; Guillon A; Si-Tahar M; Humbles AA; Courty Y
    Gene; 2016 Jul; 586(1):176-83. PubMed ID: 27080955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proposal for a unified CCN nomenclature.
    Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
    Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage.
    Kawaki H; Kubota S; Suzuki A; Lazar N; Yamada T; Matsumura T; Ohgawara T; Maeda T; Perbal B; Lyons KM; Takigawa M
    J Bone Miner Res; 2008 Nov; 23(11):1751-64. PubMed ID: 18597638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCN family of proteins: critical modulators of the tumor cell microenvironment.
    Yeger H; Perbal B
    J Cell Commun Signal; 2016 Sep; 10(3):229-240. PubMed ID: 27517291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the CCN family of proteins in female reproduction.
    Winterhager E; Gellhaus A
    Cell Mol Life Sci; 2014 Jun; 71(12):2299-311. PubMed ID: 24448904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
    Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
    J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CCN family proteins: modulators of bone development and novel targets in bone-associated tumors.
    Chen PC; Cheng HC; Yang SF; Lin CW; Tang CH
    Biomed Res Int; 2014; 2014():437096. PubMed ID: 24551846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CCN family of proteins: a 25th anniversary picture.
    Perbal A; Perbal B
    J Cell Commun Signal; 2016 Sep; 10(3):177-190. PubMed ID: 27581423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
    Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
    J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCN proteins: opportunities for clinical studies-a personal perspective.
    Yeger H
    J Cell Commun Signal; 2023 Jun; 17(2):333-352. PubMed ID: 37195381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative splicing of CCN mRNAs .... it has been upon us.
    Perbal B
    J Cell Commun Signal; 2009 Jun; 3(2):153-7. PubMed ID: 19399643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CCN family proteins in carcinogenesis.
    Dhar A; Ray A
    Exp Oncol; 2010 Mar; 32(1):2-9. PubMed ID: 20332765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene.
    Heath E; Tahri D; Andermarcher E; Schofield P; Fleming S; Boulter CA
    BMC Dev Biol; 2008 Feb; 8():18. PubMed ID: 18289368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.
    Guillon-Munos A; Oikonomopoulou K; Michel N; Smith CR; Petit-Courty A; Canepa S; Reverdiau P; Heuzé-Vourc'h N; Diamandis EP; Courty Y
    J Biol Chem; 2011 Jul; 286(29):25505-18. PubMed ID: 21628462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.